Dhruv Wellness Valuation
Is 540695 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 540695 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 540695 (₹11.56) is trading above our estimate of fair value (₹0)
Significantly Below Fair Value: 540695 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 540695?
Other financial metrics that can be useful for relative valuation.
What is 540695's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ₹121.84m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 142.1x |
Enterprise Value/EBITDA | n/a |
PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does 540695's PB Ratio compare to its peers?
Company | Forward PB | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 4.9x | ||
536565 Trimurthi | 1.9x | n/a | ₹139.2m |
538874 Nexus Surgical and Medicare | 14.8x | n/a | ₹68.4m |
SAROJA Saroja Pharma Industries India | 1.3x | n/a | ₹186.8m |
530207 Brawn Biotech | 1.4x | n/a | ₹78.2m |
540695 Dhruv Wellness | n/a | n/a | ₹121.8m |
Price-To-Book vs Peers: 540695 has negative equity and a Price-To-Book Ratio (-0.9x) compared to the peer average (4.9x).
Price to Earnings Ratio vs Industry
How does 540695's PE Ratio compare vs other companies in the IN Healthcare Industry?
Price-To-Book vs Industry: 540695 has negative equity and a Price-To-Book Ratio (-0.9x) compared to the Indian Healthcare industry average (4x).
Price to Book Ratio vs Fair Ratio
What is 540695's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PB Ratio | -0.9x |
Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate 540695's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.